BioCentury
ARTICLE | Politics, Policy & Law

NIH patent decision pushes HGSI stock down

February 14, 1994 8:00 AM UTC

NIH patent decision pushes HGSI stock down

Human Genome Sciences Inc. shares fell $2.75 to $16.25 on Friday, reflecting Wall Street's concerns about the impact of a government decision to give up on patenting human cDNA sequences. ...